MIAMI -- Oral testosterone replacement therapy (TRT) seemed safe and effective in men with testosterone deficiency, according to a meta-analysis. Among nine studies that looked at changes in serum ...

The approval was based on data from a phase 3 study that evaluated the efficacy and safety of Tlando in 95 adult hypogonadal male patients. The Food and Drug Administration (FDA) has approved Tlando™ ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved an oral testosterone undecanoate softgel for men with deficiency or absence of endogenous ...

The FDA has approved a new oral testosterone undecanoate capsule (Tlando) for hypogonadism, Antares Pharma announced. This androgen is indicated for testosterone replacement therapy in adult men for ...

RALEIGH, N.C.--(BUSINESS WIRE)--Marius Pharmaceuticals, a specialty pharmaceutical company, today announced positive preliminary data for their Phase 3 clinical trial evaluating SOV-2012-F1 in men ...

NEW YORK (Reuters Health) - A new oral testosterone undecanoate formulation can restore testosterone concentrations to normal in hypogonadal men, researchers report. "Effective as other testosterone ...

Please provide your email address to receive an email when new articles are posted on . Oral testosterone undecanoate increased serum testosterone levels to 450 ng/dL for 92% of men. A clinically ...

Testosterone plays a vital role in various bodily functions, including muscle and bone health, cognition, red blood cell and sperm formation, and sexual and reproductive function in males. Share on ...

Emily Laurence is a journalist, freelance writer and certified health coach living in Raleigh, North Carolina. She specializes in writing about mental health, healthy aging and overall wellness. For ...

The FDA has approved Kyzatrex (testosterone undecanoate) for the treatment of primary and secondary hypogonadism in adult males. The Food and Drug Administration (FDA) has approved Kyzatrex ™ ...